Mercury Patents (Class 514/496)
  • Patent number: 9682058
    Abstract: Disclosed herein are methods of treating viral infections by administration of ethyl mercury or thiol derivative thereof in an amount effective to treat the viral infection.
    Type: Grant
    Filed: March 18, 2011
    Date of Patent: June 20, 2017
    Assignee: BEECH TREE LABS, INC.
    Inventor: John McMichael
  • Publication number: 20150125407
    Abstract: The present invention relates to vesicular formulations for use in the topical administration of a biologically active agent, methods of administering a biologically active agent, a combined preparation comprising a vesicular formulation and a kit comprising a vesicular formulation.
    Type: Application
    Filed: May 10, 2013
    Publication date: May 7, 2015
    Applicant: Sequessome Technology Holdings Ltd
    Inventors: William Henry, Richard Wolf Garraway, John Mayo
  • Publication number: 20130243886
    Abstract: The present invention relates to the use of one or more compounds selected from the following classes of biologically active agents: an a-adrenergic antagonist, an anthelmintic agent, an antifungal agent, an antimalarial agent, an antineoplastic agent, an antipsychotic agent, an antioxidant, a vasodilator and/or a vitamin, or a pharmaceutically acceptable derivative thereof, for use in the treatment of a microbial infection and in particular for killing multiplying, non-multiplying and/or clinically latent microorganisms associated with such an infection.
    Type: Application
    Filed: September 9, 2011
    Publication date: September 19, 2013
    Applicant: HELPERBY THERAPEUTICS LIMITED
    Inventors: Yanmin Hu, Anthony RM Coates
  • Patent number: 8505730
    Abstract: Compositions, kits and regimens for treatment of damaged skin, especially décolletage, include application of a retinoid, hydroquinone or hydroquinone derivatives, and a composition containing a multi-metal complex.
    Type: Grant
    Filed: August 23, 2012
    Date of Patent: August 13, 2013
    Assignee: JR Chem, LLC
    Inventors: Jose E. Ramirez, Joseph R. Faryniarz
  • Publication number: 20120329649
    Abstract: This document discloses molecules having the following formula (“Formula One”): and processes associated therewith.
    Type: Application
    Filed: June 21, 2012
    Publication date: December 27, 2012
    Inventors: James E. Hunter, William C. Lo, Gerald B. Watson, Akshay Patny, Gary D. Gustafson, Dan Pernich, William K. Brewster, Debra L. Camper, Beth Lorsbach, Michael R. Loso, Thomas C. Sparks, Hemant Joshi, Adiraj Mandaleswaran, Ramadevi Sanam, Rambabu Gundla, Pravin S. Iyer
  • Publication number: 20120316259
    Abstract: This invention relates to a process for the co-encapsulation of biocidally active ingredients in a clay mineral, the process comprising the step of bringing the clay mineral into contact with a biocidally active nitrogen compound that contains at least one hydrocarbon group with 6 to 20 carbon atoms, and at the same time or subsequently with at least one biocidally active compound selected from the group consisting of 2-n-octyl-4-isothiazoline-3-one, 3-iodopropenylbutyl-carbamate and tetrahis(hydroxymethyl)phosphonium sulfate. And the use of such encapsulated product in water based paints, coatings and varnishes.
    Type: Application
    Filed: February 15, 2011
    Publication date: December 13, 2012
    Applicant: CLARIANT S.A. BRAZIL
    Inventors: Antonio Pedro de Oliveira Filho, Wagner Claudio Da Silva, Manlio Gallotti, Alexandra Paschoalin Menezes, Karine Framesqui Righi, Marcia Regina Da Silva Rios
  • Publication number: 20110286927
    Abstract: In one aspect, the invention relates to a method for identifying a drug candidate with activity as a neuroprotective agent. The method includes determining whether a compound reduces ATF4 activity; and identifying the compound that reduces ATF4 activity as a drug candidate.
    Type: Application
    Filed: August 4, 2008
    Publication date: November 24, 2011
    Applicant: CORNELL UNIVERSITY
    Inventor: Rajiv R. Ratan
  • Publication number: 20110230554
    Abstract: Disclosed herein are methods of treating viral infections by administration of ethyl mercury or thiol derivative thereof in an amount effective to treat the viral infection.
    Type: Application
    Filed: March 18, 2011
    Publication date: September 22, 2011
    Applicant: BEECH TREE LABS, INC.
    Inventor: John McMichael
  • Publication number: 20110086110
    Abstract: The present invention provides analogs of benzoquinone-containing ansamycins and uses thereof for treating and modulating disorders associated with hyperproliferation, such as cancer. The present invention provides analogs of benzoquinone-containing ansamycins where the benzoquinone is reduced to a hydroquinone and trapped by reaction with a suitable acid, preferably ones that increase the solubility and air stability of the resulting 17-ammonium hydroquinone ansamycin analog.
    Type: Application
    Filed: October 6, 2010
    Publication date: April 14, 2011
    Applicant: Infinity Discovery, Inc.
    Inventors: Julian Adams, Yun Gao, Asimina T. Georges Evangelinos, Louis Grenier, Roger H. Pak, James R. Porter, James L. Wright
  • Publication number: 20100255120
    Abstract: The invention is directed to enzyme immobilization compositions comprising: one or more enzymes, a humectant, an acrylic-based monomer, a water-soluble organic photo-initiator and a water-soluble acrylic-based cross-linker in a substantially homogeneous aqueous mixture. The invention is also directed to methods for forming sensors comprising such compositions and to apparati for forming arrays of immobilized layers on an array of sensors by dispensing such compositions onto a substrate.
    Type: Application
    Filed: December 20, 2007
    Publication date: October 7, 2010
    Inventors: Gordon Bruce Collier, Jason Andrew Macleod, Anjulia Wong, Attila Csaba Nemeth
  • Publication number: 20100092578
    Abstract: The invention involves PKC? signaling. The invention provides, for example, transgenic animals, inhibitors of PKC? signaling, methods for inhibiting PKC? signaling, methods for identifying inhibitors of PKC? signaling, and methods for diagnosing cancer.
    Type: Application
    Filed: October 1, 2009
    Publication date: April 15, 2010
    Inventors: Alan P. Fields, Nicole Renee Murray, Melody Lee Stallings-Mann, Lee Jamieson
  • Publication number: 20090324714
    Abstract: A dual adhesive layer dosage form for delivery of active agent to and across, the mucosa is disclosed. Particularly, bioadhesive tablets for administration at the vaginal mucosa are disclosed as having a central active layer sandwiched between two bioadhesive layers.
    Type: Application
    Filed: June 26, 2009
    Publication date: December 31, 2009
    Applicant: WYETH
    Inventors: Xiuying LIU, John KRESEVIC
  • Publication number: 20080292673
    Abstract: Bioactive agrichemical concentrates and compositions having improved bioactivity comprising combinations of acid solutions and conventional bioactive agrichemical actives or formulations.
    Type: Application
    Filed: May 19, 2008
    Publication date: November 27, 2008
    Inventor: Joseph J. Crudden
  • Publication number: 20080292674
    Abstract: Bioactive agrichemical concentrates and compositions having improved bioactivity comprising combinations of acid solutions and conventional bioactive agrichemical actives or formulations.
    Type: Application
    Filed: May 19, 2008
    Publication date: November 27, 2008
    Inventor: Joseph J. Crudden
  • Patent number: 7323452
    Abstract: A method for accelerating the process of removing ethanol from the blood through the use of certain additives that accelerate the metabolic oxidation of ethanol, and others which in addition act as catalysts or “pseudo” enzymes for the oxidation. These additives include multivalent transition metal ions, as well as complexes thereof, and NAD+ which enhance the oxidation reaction. The method described can act as a sobriety inducer and/or as an effective palliative for the unpleasant effects of overuse of ethanol.
    Type: Grant
    Filed: December 20, 2004
    Date of Patent: January 29, 2008
    Assignee: Wardan, L.L.C.
    Inventors: Ward B. Bowen, Jr., Daniel S. Daniel
  • Patent number: 7067551
    Abstract: The present invention provides hydroxamate compounds which are deacetylase inhibitors. The compounds are suitable for pharmaceutical compositions having anti-proliferative properties.
    Type: Grant
    Filed: November 9, 2004
    Date of Patent: June 27, 2006
    Assignee: Novartis AG
    Inventors: Stacy W Remiszewski, Kenneth W Bair, Richard W Versace, Lawrence B Perez, Michael A Green, Lidia C Sambucetti, Sushil Sharma
  • Patent number: 6833362
    Abstract: A composition for accelerating the disposal of ethanol from bodily fluid. Certain additives can accelerate the metabolic oxidation of ethanol, and others in addition act as catalysts or “pseudo” enzymes for the oxidation. Additives include the oxidant Nicotinamide Adenine Dinucleotide and a variety of other additives such as transition metal ions and complexes thereof which favor the oxidation reaction. The compositions described can act as a sobriety inducer and/or as an effective palliative for the unpleasant effects of overuse of ethanol.
    Type: Grant
    Filed: June 7, 2001
    Date of Patent: December 21, 2004
    Inventors: Ward Beryl Bowen, Jr., Daniel Salman Daniel
  • Patent number: 6770674
    Abstract: A mollusc repellent, which includes a substantially insoluble metal oxalate and a suitable carrier therefor, which exhibits prolonged efficacy. The mollusc repellent is environmentally friendly, being both non-phytotoxic and harmless to non-target animals, and is therefore suitable for use in sustainable agriculture, where the use of toxic chemicals is unacceptable. The mollusc repellent can be used in the form of a solid or as a coating composition.
    Type: Grant
    Filed: February 9, 2001
    Date of Patent: August 3, 2004
    Inventor: Colin Leslie Young
  • Use
    Publication number: 20030225117
    Abstract: The present invention relates to the use of NAD(P)H oxidase inhibitors to increase cellular uptake of glucose and in the treatment and/or prevention of diseases caused by insulin resistance or diseases related thereto, such as type II diabetes. Specifically, the invention relates to a method for identifying an agent useful for the treatment or prophylaxis of a medical condition associated with elevated levels of blood glucose, the method comprising (i) contacting a candidate agent with a mammalian NAD(P)H oxidase or NAD(P)H oxidase complex; and (ii) determining whether said candidate agent inhibits the biological activities of the NAD(P)H oxidase or NAD(P)H oxidase complex.
    Type: Application
    Filed: April 17, 2003
    Publication date: December 4, 2003
    Inventors: Alvar Gronberg, Per Wikstrom
  • Patent number: 6630172
    Abstract: Disinfectant formulations are described which are preferably ecologically friendly and non-toxic to mammals and plants, and are highly effective against a broad spectrum of detrimental pathogenic microorganisms. The microbicidal formulation contains complexes having at least one metal ion which is microbicidal to at least one microorganism and potassium sodium tartrate in some form. When potassium sodium tartrate is used with these metal ions, it enhances the complex-forming properties of such metal complexes while concurrently increases their efficacy and potency at the same level of metal ion concentrations. These microbicidal formulations can be diluted in suitable proportions into aqueous systems to produce the desired dosages for each individual case, depending on the level and the severity of the contamination. The microbicidal formulations can be applied by conventional methods, e.g., spraying, soaking, fogging, impregnation, and the like.
    Type: Grant
    Filed: January 22, 2001
    Date of Patent: October 7, 2003
    Inventor: Kareem I. Batarseh
  • Patent number: 6521265
    Abstract: A method of arresting the flow of blood and other protein containing body fluids flowing from an open wound and for promoting wound healing. In the method, a substantially anhydrous compound of a salt ferrate is provided for a unique use which, when hydrated after mixing with a victim's own blood or other aqueous media, produces Fe+++ thereby promoting clotting when applied in a paste form to the wound for a time sufficient to arrest substantial further blood and other body fluid flow from the wound. The compound is formed of a ferrate (VI) salt taken from the group consisting of H, Li, Na, K, Rb, Cs and Fr. However, to decrease or eliminate stinging sensation, the compound may be formed having a ferrate (VI) salt taken from the group consisting of Be, Mg, Ca, Sr, Ba, Ra, Ti, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, Ga, Ge, Zr, Nb, Mo, Tc, Ru, Rh, Pd, Ag, Cd, In, Sn, Hf, Ta, W, Re, Os, Ir, Pt, Au, Hg, TI, Pb, Bi, Al, As, NH4 and N(C4H9)4.
    Type: Grant
    Filed: June 13, 2000
    Date of Patent: February 18, 2003
    Assignee: Biolife, L.L.C.
    Inventor: James A. Patterson
  • Patent number: 6426093
    Abstract: A biocidal composition composed of a ternary complex of a negatively-charged biocide, a transition metal ion and chelator has synergistic biocidal effects as compared with a composition of each of the components alone. The chelator is preferably a neutral or positively-charged chelator. The ternary complex may be used for killing or inhibiting the growth of living cells.
    Type: Grant
    Filed: February 9, 1999
    Date of Patent: July 30, 2002
    Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem
    Inventors: Mordechai Chevion, Benzhan Zhu, Svetlana Schechtman
  • Patent number: 6333432
    Abstract: Fungicidal compositions and methods comprising acylated aminosalicylamides (AASA) described herein. Novel amines and 3-nitrosalicylamides, and their use as pesticides and in the preparation of the antifungal AASA compounds are also disclosed.
    Type: Grant
    Filed: May 1, 2000
    Date of Patent: December 25, 2001
    Inventors: Gina M. Fitzpatrick, Ann B. Orth, Maurice C. H. Yap, Richard B. Rogers, Todd L. Werk, George E. Davis
  • Patent number: 6310093
    Abstract: Disclosed is a method for preventing neuronal cell death subsequent to an injury to neuronal tissue, particularly central nervous tissue exposed to an ischemic or hypoxic event, to trauma or to a chronic neurodegenerative disorder. The method includes exposing the cells to a glutaminase inhibitor that is relatively impermeant to healthy, intact cell membranes, and which is preferably a specific inhibitor of the form of glutaminase that is widely present in brain tissue.
    Type: Grant
    Filed: August 27, 1998
    Date of Patent: October 30, 2001
    Assignee: Elan Pharmaceuticals, Inc.
    Inventor: Robert Newcomb
  • Patent number: 6177480
    Abstract: An agent for contact lenses, which comprises an aqueous medium and synthetic smectites particulates consisting essentially of primary particles having a particle size of at most 200 nm, dispersed in the aqueous medium.
    Type: Grant
    Filed: March 23, 1999
    Date of Patent: January 23, 2001
    Assignee: Menicon Co., Ltd.
    Inventors: Akira Tsuzuki, Osamu Mori
  • Patent number: 6174916
    Abstract: Methods and compositions are provided for alleviation of disease states involving plaque formation, such as are manifested in Alzheimer's Disease and other amyloid disorders, and arteriosclerotic disease. Methods for the treatment of herpes virus infections including chronic fatigue syndrome by administration of thimerosal are further provided by the invention.
    Type: Grant
    Filed: April 1, 1998
    Date of Patent: January 16, 2001
    Assignee: Milkhaus Laboratory, Ltd.
    Inventor: John McMichael
  • Patent number: 6071956
    Abstract: An exogenous stimulus is applied to tissues or cells which are at risk in a subsequent surgical procedure or other intervention which induces a response by the cells that minimizes reaction to the subsequent procedure. Stimuli can be chemical, physiological or physical. Examples include those stimuli known to induce expression of stress response proteins or heat shock proteins, especially heat shock protein 70 (hsp 70) and hsp 90, for example, exposure to heat or dilute hydrogen peroxide, or direct administration of exogenous heat shock proteins, or those stimuli which act to inhibit or reduce heat shock protein expression, for example, treatment with flavonoids.
    Type: Grant
    Filed: September 23, 1998
    Date of Patent: June 6, 2000
    Assignee: Endoluminal Therapeutics, Inc.
    Inventors: Marvin J. Slepian, Stephen P. Massia
  • Patent number: 5916356
    Abstract: This invention relates to preservative compositions which comprise a biocidal metal compound and an fungicidal compound containing a triazole group. Methods of treating wood with the composition are also described.
    Type: Grant
    Filed: June 2, 1997
    Date of Patent: June 29, 1999
    Assignee: Hickson International PLC
    Inventors: Gareth Williams, Judith Ann Cornfield, Janet Brown, Neil Patrick Ryan
  • Patent number: 5914345
    Abstract: An exogenous stimulus is applied to tissues or cells which are at risk in a subsequent surgical procedure or other intervention which induces a response by the cells that minimizes reaction to the subsequent procedure. Stimuli can be chemical, physiological or physical. Examples include those stimuli known to induce expression of stress response proteins or heat shock proteins, especially heat shock protein 70 (hsp 70) and hsp 90, for example, exposure to heat or dilute hydrogen peroxide, or direct administration of exogenous heat shock proteins, or those stimuli which act to inhibit or reduce heat shock protein expression, for example, treatment with flavonoids.
    Type: Grant
    Filed: October 11, 1994
    Date of Patent: June 22, 1999
    Assignee: Endoluminal Therapeutics, Inc.
    Inventors: Marvin J. Slepian, Stephen P. Massia
  • Patent number: 5889048
    Abstract: A pharmaceutical formulation having immunomodulating and regenerating effect on abnormal function of cell tissue division-regulating system comprises, as an active ingredient, mercury dichloride or potassium arsenite or sodium arsenate in the amount of 0.01-1.5% by weight and of a diluent up to 100% by weight. The proposed pharmaceutical formulation preferably contains natural white grape wine with sugar content of 3-4% by weight or whey with sugar content of 3-4% by weight as the diluent.
    Type: Grant
    Filed: August 19, 1996
    Date of Patent: March 30, 1999
    Inventor: Tamara Vasilievna Vorobieva
  • Patent number: 5534542
    Abstract: Disclosed herein is a bi-metallic cross-linking reagent according to the following formula: ##STR1## where M.sub.1 is a metal ion species capable of forming a complex of coordination number four or coordination number six; wherein L.sub.1, L.sub.2, L.sub.3, and L.sub.4 are each independently a halide, ammonia, dimethyl sulfoxide, carboxylate, thiolate, imidazole, a nucleobase, or an empty coordination site, provided that no more than two of L.sub.1, L.sub.2, L.sub.3, and L.sub.4 are empty coordination sites; wherein M.sub.2 is a metal ion species capable of forming a complex of coordination number two with a first ligand that is a hydrocarbon moiety and a second ligand that is kinetically lablie; and wherein n is an integer from two to nine. Also disclosed are cross-linked species, methods of preparing the crosslinking reagents of the invention, and methods for their use in tissue-specific targeting of anti-tumor agents.
    Type: Grant
    Filed: January 24, 1994
    Date of Patent: July 9, 1996
    Assignee: Northwestern University
    Inventors: Thomas V. O'Halloran, Stephen P. Watton
  • Patent number: 5198011
    Abstract: Methods are provided for inhibition of leaf rust infections of plants, especially wheat, using inhibitors which disrupt sulfhydryl bonds of the enzymes used by the leaf rust germ tube to ingest and metabolize components of epicuticular waxes.
    Type: Grant
    Filed: August 1, 1988
    Date of Patent: March 30, 1993
    Assignee: The United States of America as represented by the Secretary of Agriculture
    Inventors: Robert E. Wilkinson, John J. Roberts
  • Patent number: 4891356
    Abstract: A method of treating gastrointgestinal ulcer disease is provided which involves administration of a proteinase inhibitor or analogue to patients suffering from same. Of particular interest is the use of inhibitors of serine, cysteine, carboxyl, and metallo proteinases.
    Type: Grant
    Filed: July 15, 1987
    Date of Patent: January 2, 1990
    Assignee: Brigham & Women's Hospital
    Inventor: Sandor Szabo
  • Patent number: 4851398
    Abstract: The invention relates to a method for making a composition which comprises selecting at least one fatty acid or fatty ester compound having an allylic unsaturation of the type --CH.dbd.CH--CH.sub.2 --CH.dbd.CH-- or --CH.dbd.CH--CH.dbd.CH--CH.sub.2 --, adding to said compound a salt of an element having a rhombohedral crystal structure, such as Bi, Hg, As, B, Sb or Sm, to form a mixture, heating said mixture above about 260.degree. C. for a sufficient period of time to incorporate at least about 0.1% by weight of the element into the compound, cooling the mixture, and recovering the incorporated compound as the remaining fluid of the mixture. The invention also relates to the reaction products thus produced along with methods of administering these compositions to a subject to treat abnormal conditions caused mainly by a catabolic imbalance.
    Type: Grant
    Filed: September 30, 1987
    Date of Patent: July 25, 1989
    Assignee: Elena Avram
    Inventor: Emanuel Revici
  • Patent number: 4829083
    Abstract: The invention relates to the stabilization of mercury-containing preservatives in liquid or gel-form ophthalmic medicaments. This stabilization against chemical decomposition after the preservative has become deposited on the inner walls of the plastics containers is achieved by adding to the formulation 2-amino-2-hydroxymethyl-1,3-propanediol or a homologue thereof having up to 10 carbon atoms.
    Type: Grant
    Filed: April 14, 1987
    Date of Patent: May 9, 1989
    Assignee: Dispersa AG
    Inventor: Johann Doulakas
  • Patent number: 4680309
    Abstract: A method of treating inflammation or arthritis with metal complexes that can traverse skin and animal cell membranes intact and effectively deliver and release metal ions in a controlled manner upon demand at the targeted inflammatory or arthritic areas containing endogenous reacting moieties which demand the metal ions. The metal complexes have an aqueous proton induced dissociation property represented by a sigmoidally-shaped curve on a cartesian coordinate plot of the negative log of the metal ion concentration versus the negative log of hydrogen ion concentration. This dissociation property enables the metal complexes to release metal ions in a controlled manner upon demand at the targeted inflammatory or arthritic areas containing endogenous reacting moieties which demand the metal ions. The metal complexes can be effectively administered either topically or subcutaneously.
    Type: Grant
    Filed: February 3, 1986
    Date of Patent: July 14, 1987
    Assignee: National Research Laboratories
    Inventor: Gerald L. Maurer
  • Patent number: 4612255
    Abstract: Water dispersible compositions containing hydrocarbon wax are described which are useful in preparing aqueous water repellent systems. Aqueous water repellent systems containing a hydrocarbon wax also are described. The water repellent system comprises an aqueous system comprising water, a saturated hydrocarbon wax, at least one oil-soluble metal salt of an organic carboxylic acid, at least one surfactant and at least one hydrocarbon solvent. A process for impregnating permeable substrates such as wood, cloth, concrete, rope, etc. with the water repellent system is also described. Penetration of the various components into the substrate is obtained by brushing, dipping, soaking, spraying or immersion at atmospheric pressure, at elevated pressures or under vacuum. The oil-soluble metal salt often is a fungicide. Moreover, additional components can be contained in the aqueous system such as insecticides, colorants, flame retardants, moldicides, wood stabilizing agents, etc.
    Type: Grant
    Filed: December 18, 1984
    Date of Patent: September 16, 1986
    Assignee: Mooney Chemicals, Inc.
    Inventor: Richard W. Hein
  • Patent number: 4579960
    Abstract: Buffered aqueous solution of thimerosal wherein the buffer is citric acid and sodium citrate having a pH between 3.5 and 7.
    Type: Grant
    Filed: May 7, 1984
    Date of Patent: April 1, 1986
    Assignee: Schering Corporation
    Inventors: Pui-Ho Yuen, Shreeram Agharkar
  • Patent number: 4556721
    Abstract: New mercurobutol derivatives characterized in that they comprise at least one functional group, bonded to the mercurobutol phenol ring, which functional group being capable of intervening in a polymerization or polyaddition reaction, and said derivatives having the bioactive properties of mercurobutol, even after such reaction.These new derivatives can intervene in a grafting operation either as termination agent or a polymerization agent.These new derivatives, when grafted on a support, give it protection against bacteria, mushrooms and other micro-organisms.
    Type: Grant
    Filed: January 13, 1984
    Date of Patent: December 3, 1985
    Assignee: Centre Technique Industriel Styled: Institut Textile
    Inventors: Daniel Wattiez, Roger Chatelin, Michel Bourgeois
  • Patent number: 4539235
    Abstract: A method for treating wood with an aqueous composition having fungicidal and insecticidal properties. The aqueous composition comprises(a) at least one oil-soluble metal salt of an organic carboxylic acid having fungicidal properties wherein the metal is zinc, chromium, iron, antimony, lead, mercury or a mixture thereof,(b) at least one halopyridyl phosphate of the formula ##STR1## wherein R represents a halopyridyl group, Z represents oxygen or sulfur, and each R' is independently a lower alkoxy, amino or lower alkylamino group,(c) at least one surfactant, and(d) from about 60 to 99% of water.Such compositions penetrate into both dry and green wood rather readily, and the result is wood which is resistant to fungi and insects.
    Type: Grant
    Filed: November 19, 1984
    Date of Patent: September 3, 1985
    Assignee: Mooney Chemicals, Inc.
    Inventors: Albert V. Collins, Richard W. Asmus
  • Patent number: 4507152
    Abstract: An aqueous composition having fungicidal and insecticidal properties is described which is useful particularly for treating wood. The aqueous composition comprises(a) at least one oil-soluble metal salt of an organic carboxylic acid having fungicidal properties wherein the metal is zinc, chromium, iron, antimony, lead, mercury or a mixture thereof,(b) at least one halopyridyl phosphate of the formula ##STR1## wherein R represents a halopyridyl group, Z represents oxygen or sulfur, and each R' is independently a lower alkoxy, amino or lower alkylamino group,(c) at least one surfactant, and(d) from about 60 to 99% of water.Such compositions penetrate into both dry and green wood rather readily, and the result is wood which is resistant to fungi and insects.
    Type: Grant
    Filed: December 2, 1983
    Date of Patent: March 26, 1985
    Assignee: Mooney Chemicals, Inc.
    Inventors: Albert V. Collins, Richard W. Asmus
  • Patent number: RE32909
    Abstract: Metal oxycarboxylates are made by reacting a metal, a carboxylic acid, and hydrogen peroxide in aqueous reaction mixture. The metal oxycarboxylate is precipitated and removed from the reaction mixture in high yield and with high purity. The compound is effective in supplying the metal to plants, animals and humans.
    Type: Grant
    Filed: June 18, 1984
    Date of Patent: April 18, 1989
    Assignee: BioSystems Research Inc.
    Inventors: Joseph E. Lionelle, Jeffrey A. Staffa